pocketful logo light
pocketful logo light
Lincoln Pharmaceuticals Ltd logo

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN BSE: 531633

₹615.50

(0.58%)

Thu, 16 Jul 2026, 07:41 am

mtf coin illustrationMTF 5x

Lincoln Pharmaceuticals Share Price Live Chart

1 Day

(0.58%)

No Result Found

Summary

  • Market Cap (in Cr)

    1265.68

  • Net Profit (in Cr)

    82.35

  • P/B

    1.64

  • Sector P/E

    33.76

  • P/E

    13.42

  • EV/EBITDA

    8.73

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    13.02

  • ROCE

    17.42

  • Debt/Equity

    0

  • EPS (TTM)

    43.88

  • Dividend Yield

    0.28

  • Book Value

    378.25

  • Interest Cover

    59.08

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters49.7849.7849.7849.7849.78
FII5.194.704.725.145.00
DII1.090.010.010.010.01
Public43.9445.5245.4945.0745.22
Government00000

Read More

Technical Analysis

RSI

41.14

MACD

-8.56

50 DMA

643.57

200 DMA

565.90

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic771.38697.03660.27622.68585.92548.33473.98
Fibonacci697.03668.63651.09622.68594.28576.74548.33
Camarilla643.95637.13630.32622.68616.68609.87603.05

Pivots Level: Classic

R3

+148.70

771.38

R2

+74.35

697.03

R1

+37.58

660.27

622.68
622.68
Pivot Point
LTP: 600

S1

-36.77

585.92

S2

-74.35

548.33

S3

-148.70

473.98

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    609.64

  • 20-EMA

    616.21

  • 30-EMA

    621.33

  • 50-EMA

    624.22

  • 100-EMA

    612.09

  • 200-EMA

    593.30

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
28 May 2026board-meetingsAccounts, Quarterly Results, Dividend
12 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
29 Aug 2025agm
12 Aug 2025dividendFinal Dividend - Rs. - 1.812 Sept 2025
22 May 2025dividend₹1.80 Dividend /Share12 Sept 2025
02 Sept 2024agm
13 Aug 2024dividendDividend - Rs 1.80 Per Share14 Sept 2024
16 May 2024dividend₹1.80 Dividend /Share14 Sept 2024
26 Aug 2023agm

Read More

Peer Comparison

Lincoln Pharmaceuticals Ltd logo

Lincoln Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Lincoln Pharmaceuticals Ltd About

Lincoln Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceutical products.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1995

Headquarters

CEO

Kishorbhai M Shah

Employees

Contact

Website icon

Website

http://www.lincolnpharma.com

Email icon

Email

cs@lincolnpharma.com; investor@lincolnpharma.com

Phone icon

Phone

91-079-67778000

Location icon

Location

Lincoln House B/H Satyam Compe, Science City Road Sola, Ahmedabad, Gujarat, 380060

Read More

Lincoln Pharmaceuticals Ltd Company History

YearHistory
2014
  • Lincoln Pharmaceuticals Ltd has launched an Ultramodern State of Art plant for Injectable.
  • Company has commended the payment of Dividend of Rs. 0.60/- per equity share (@ 6%) of face value of Rs. 10/- each of the Company.
2015
  • The company has successfully launched a cough syrup called Namcold DX which contains Dextromethorphan Polistrirex.
2016
  • Lincoln Pharmaceuticals launches Vaginal Spray for FIRST TIME IN INDIA.
2020
  • Lincoln Pharma gets Gujarat food & drug regulator nod to manufacture COVID-19 drugs.
  • The company has received approval from the state regulator to manufacture varied dosages of HCQ tablets and HCQ sulfate tablets among others at Khatraj plant.
2021
  • The company received approval for the company's manufacturing facility from Australia's medicines and medical devices regulator.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy208466707.5129 Apr 2026
QE SECURITIES LLPbulkBuy109936701.4629 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell208466707.9329 Apr 2026
QE SECURITIES LLPbulkSell106989709.2829 Apr 2026
GREENX WEALTH MULTIHORIZONS OPPORTUNITY FUNDbulkBuy165255603.0712 Feb 2026
MUSIGMA SECURITIESbulkSell160300606.0407 Aug 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell275585600.3907 Aug 2025
IRAGE BROKING SERVICES LLPbulkBuy92372599.3507 Aug 2025
MUSIGMA SECURITIESbulkBuy160300604.9707 Aug 2025
IRAGE BROKING SERVICES LLPbulkSell104690598.8707 Aug 2025

Read More

Lincoln Pharmaceuticals Ltd News

Lincoln Pharma FY26 net profit rises 6.74%

Lincoln Pharmaceuticals reported a FY26 net profit of ₹87.89 crore, up 6.74% YoY. The board recommended a dividend of ₹1.80 per share.

28 May 2026

companies

Lincoln Pharma Board Meet Set for May 28, 2026

Lincoln Pharmaceuticals' board will meet on May 28, 2026 to consider audited standalone and consolidated financial results for Q4 and FY26, along with a possible dividend recommendation.

18 May 2026

companies

Lincoln Pharma Issues IEPF Share Transfer Notice

Lincoln Pharmaceuticals Ltd published a newspaper advertisement on May 08, 2026, notifying shareholders of equity share transfers to IEPF Authority for unclaimed dividends over seven consecutive years.

08 May 2026

companies

Lincoln Pharma Confirms Non-Large Corporate Status

Lincoln Pharmaceuticals Limited informs stock exchanges that it does not qualify as a Large Corporate under SEBI framework for FY 2026-27, submitting required disclosure as per regulatory circular.

16 Apr 2026

companies

Lincoln Pharma Files Q4FY26 SEBI Compliance Certificate

Lincoln Pharmaceuticals Limited submitted its quarterly confirmation certificate under SEBI Depositories Regulations for Q4FY26, confirming proper dematerialisation processes through registrar MUFG Intime India.

06 Apr 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number